News | September 16, 2022
Pharmexcil to organise exhibition on pharma and healthcare on Sept 21-23
The event is supported by the Ministry of Commerce & Industry, Government of India and CDSCO, Ministry of Health.
The event is supported by the Ministry of Commerce & Industry, Government of India and CDSCO, Ministry of Health.
The objective of this study is to evaluate the efficacy of ASC22 (Envafolimab) combined with Chidamide on the viral reservoirs of latently infected cells in HIV patients.
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
The company has partnered with Neethi, a Kerala state cooperative consumers federation limited company, to run this program in Kerala
Pfizer’s Paxlovid is approved by US FDA for COVID treatment
The plant is a dedicated for manufacturing of Mouth dissolving strip.
Proceeds from the proposed issue will be utilized to part finance Balaxi’s planned EU GMP-compliant manufacturing facility for Oral Solid Dosages and Liquid Injectables at TSIIC Pharma Formulations SEZ
Phase 2 study to assess efficacy and safety of once daily linperlisib in patients with advanced peripheral T/NK cell lymphoma
Dr. Mahdavi will lead Ginkgo's commercial efforts in the growing areas of bio-reagents, cell and gene therapies and new biopharmaceutical modalities.
NATCO to sell 15% of shareholding in Nativita for euro 3,45,000 to Pharmasyntez-Nord
Subscribe To Our Newsletter & Stay Updated
